Firms

Nexus NeuroTech Ventures

Nexus NeuroTech Ventures

San Francisco, California

Invested in neurotechnology startups developing treatments and tools for neurological conditions, including brain-computer interfaces. The firm states that its operations concluded on March 31, 2026.

Founded
2023
Type
Venture capital

Funds1

  • Nexus NeuroTech Fund II, L.P.$126M

    The March 20, 2025 SEC notice reports a $126 million offering fully sold to two investors, with the first sale on March 14, 2025.

Team

No team members on record yet.

Co-investing

Investments